Where to Invest in US Drug Manufacturing

As tariffs rise and the government pushes for more domestic production, new opportunities for private equity investment are opening up in the U.S. CDMO market. In this short, David Williams breaks down the three hottest areas for private equity investment: sterile injectables, continuous manufacturing, and quality-driven roll-ups.

Learn how to identify the next big value plays in pharma manufacturing.

Previous
Previous

Tariffs Are Good?! Why U.S. Drug Manufacturers Are the Real Winners

Next
Next

Every Patient Deserves An AI Pre-Visit